Blood Clots Risk: Heightened Among Discharged Cancer Patients

Recommend to others!

Many health issues regarding the use of chemotherapy among cancer patients are on the main stream. These issues arise after certain researches found out that the chemotherapy among patients can actually cause cognitive issues which involve slight problems in thinking, memorizing, and identifying objects that begin with a specific letter. Although the presence of these health issues is indeed bothersome, still the use of chemotherapy among patients who are suffering from various kinds of cancer remains effective and applicable. These are just but some of the side effects that a person who is under chemotherapy can experience. Support and medical interventions to lessen the side effects should be given to the person undergoing chemotherapy.

Recently, another health issue regarding the use of chemotherapy has been named, and this is the risk of blood clots. According to a new large study, cancer patients who are undergoing chemotherapy are of increased risk of developing blood clots after they are discharged from the hospital.

The new study is scheduled to be presented Monday at the American Society of Hematology annual meeting in San Diego. In addition, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

The development of blood clot or medically known as venous thromboembolism is considered risky. Because these blood clots can be circulated in the blood vessels and can then block or obstruct small arteries which supplies nutrients to different body cells.

In the study, the researchers included the analysis and evaluation of data gathered from about 18,000 patients who have cancer. These cancer patients were tracked down by the researchers for more than four years. After that span of time, researchers found out that among the 18,000 cancer patients, about 2.6 per cent of them had developed blood clots. In addition, the researchers noted that about 78 per cent of these study participants were receiving chemotherapy as out-patients. Hence, the researchers noted that continuous monitoring and observation of patients in terms of the risk of developing blood clots should be more meticulous among those patients who are receiving the treatment as out-patients as compared to those who are receiving it while they are admitted in the hospital.

Moreover, according to study author Dr. Alok Khorana, an associate professor in the James P. Wilmot Cancer Center at URMC, Khorana said: “Patients should immediately report to their physicians any unusual symptoms such as swelling or redness in limbs, or shortness of breath, even if they are otherwise feeling well.”





  1. [...] Cancer cells don’t usually thrive in laboratory conditions and hence studying them or administering proper diagnosis was an issue. Previously doctors have relied on biopsied tissue frozen into wax to recommend treatments. With the possibility of cancer cells thriving in labs, scientists can help doctors to come up with much better treatment and also observe the cancer cells more closely that could lead to further breakthroughs in cancer research. [...]

  2. [...] It’s usually the individuals who underwent a surgery who account for over 60-70% of the blood transfusions. The older patients are, the more blood transfusions are accounted for [...]

Speak Your Mind


Current day month ye@r *